CDKN2A and cancer: This suggests that while TRIP12 plays a cancer transformation promoting role in p14ARF positive normal fibroblast cells through the degradation of p14ARF resulting in loss of OIS, TRIP12 might play an EMT inhibitory role in p14ARF absent immortalized MCF10A cells, which have overcome OIS during the process of immortalization.